FGF-23 in acute heart failure with reduced ejection fraction: is it useful to predict admissions?

9 May 2026 (08:00 - 12:45)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Antonio Jose Bollas Becerra

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

5 More presentations in this session

Presentation thumbnail

Prevalence of potential primary aldosteronism in patients with heart failure with reduced ejection fraction: a post hoc analysis of the ALOFT trial

Doctor M. Chimura (Glasgow, GB)

Abstract Slides

Presentation thumbnail

Do endothelial markers possess a role in the evaluation of decongestion and prediction of adverse cardiovascular events in hospitalised patients with acute decompensated heart failure?

Doctor J. Jurica (Martin, SK)

Abstract Slides

Presentation thumbnail

SuPAR, a new prognostic marker in acute heart failure with reduced ejection fraction?

Doctor A. Bollas Becerra (Madrid, ES)

Abstract Slides

Presentation thumbnail

Circulating mitochondrial and metabolic biomarkers in HFpEF: from energetic failure to clinical prediction - a systematic review

Ms S. Satishkumar (Tbilisi, GE)

Abstract Slides

Presentation thumbnail

Association between soluble ST2 levels and pulmonary congestion in heart failure

Doctor M. Kobayashi (Tokyo, JP)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - biomarkers (4)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

You may be interested in

Congress Session

From genetic signatures to clinical implications

Congress Presentation

A proteo-genomic discovery approach to identify markers of early heart failure

Congress Presentation

State-of-the-art lecture on current state of the diagnosis of heart failure

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources